IMMURON Net Worth 2018-2019 | IMRN

Interactive chart of historical net worth (market cap) for IMMURON (IMRN) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. IMMURON net worth as of December 05, 2019 is $0.01B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.013B $0.002B
Immuron Limited is a bio pharmaceutical Microbiome company. It focused on oral immunotherapy using polyclonal antibody products for humans. The company is involved in developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis. Immuron Limited is based in Armadale, Australia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.308B 15.93
CSL (CSLLY) Australia $85.405B 0.00
Gilead Sciences (GILD) United States $83.588B 10.36
Vertex Pharmaceuticals (VRTX) United States $56.863B 58.04
Biogen (BIIB) United States $52.454B 9.00
Illumina (ILMN) United States $47.477B 52.09
Regeneron Pharmaceuticals (REGN) United States $40.493B 17.73
Alexion Pharmaceuticals (ALXN) United States $25.238B 12.46
Seattle Genetics (SGEN) United States $20.383B 0.00
Incyte (INCY) United States $20.269B 47.05
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Genmab (GNMSF) Denmark $14.513B 64.10
BioMarin Pharmaceutical (BMRN) United States $14.411B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.643B 0.00
Galapagos (GLPG) Belgium $11.053B 28.48
Exact Sciences (EXAS) United States $10.807B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
BeiGene (BGNE) Cayman Islands $9.600B 0.00
QIAGEN (QGEN) Netherlands $9.593B 31.28
Sarepta Therapeutics (SRPT) United States $8.297B 0.00
Bio-Techne Corp (TECH) United States $8.214B 54.98
Amarin (AMRN) Ireland $7.727B 0.00
Moderna (MRNA) United States $7.092B 0.00
Guardant Health (GH) United States $7.062B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.922B 0.00
Medicines (MDCO) United States $6.705B 0.00
Reata Pharmaceuticals (RETA) United States $6.134B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.042B 15.36
ARGENX SE-ADR (ARGX) Netherlands $5.609B 0.00
Exelixis (EXEL) United States $5.065B 14.25
Ascendis Pharma (ASND) Denmark $4.793B 0.00
Bluebird Bio (BLUE) United States $4.696B 0.00
China Biologic Products (CBPO) China $4.597B 25.90
Repligen (RGEN) United States $4.570B 82.82
Spark Therapeutics (ONCE) United States $4.272B 0.00
Mirati Therapeutics (MRTX) United States $4.133B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.037B 0.00
MorphoSys AG (MOR) Germany $3.985B 0.00
Blueprint Medicines (BPMC) United States $3.775B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.728B 0.00
Immunomedics (IMMU) United States $3.674B 0.00
Adaptive Biotechnologies (ADPT) United States $3.353B 0.00
Alkermes (ALKS) Ireland $3.191B 0.00
Genmab (GMAB) Denmark $3.064B 6.31
MyoKardia (MYOK) United States $3.029B 0.00
UniQure (QURE) Netherlands $2.788B 0.00
Emergent Biosolutions (EBS) United States $2.770B 27.52
Halozyme Therapeutics (HALO) United States $2.739B 0.00
Amicus Therapeutics (FOLD) United States $2.737B 0.00
NeoGenomics (NEO) United States $2.670B 142.06
Acceleron Pharma (XLRN) United States $2.593B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.401B 0.00
Zai Lab (ZLAB) China $2.354B 0.00
Arena Pharmaceuticals (ARNA) United States $2.301B 5.35
RA PHARMCTL INC (RARX) United States $2.215B 0.00
Insmed (INSM) United States $2.052B 0.00
Ligand Pharmaceuticals (LGND) United States $1.950B 37.50
Myriad Genetics (MYGN) United States $1.843B 27.23
Dicerna Pharmaceuticals (DRNA) United States $1.771B 0.00
Denali Therapeutics (DNLI) United States $1.702B 0.00
Zymeworks (ZYME) Canada $1.695B 0.00
REGENXBIO (RGNX) United States $1.638B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.634B 0.00
Akcea Therapeutics (AKCA) United States $1.623B 0.00
Editas Medicine (EDIT) United States $1.554B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.520B 0.00
Epizyme (EPZM) United States $1.448B 0.00
Alector (ALEC) United States $1.340B 0.00
Sangamo Therapeutics (SGMO) United States $1.318B 0.00
Innoviva (INVA) United States $1.314B 3.87
Arvinas (ARVN) United States $1.271B 0.00
Athenex (ATNX) United States $1.239B 0.00
Coherus BioSciences (CHRS) United States $1.226B 0.00
WAVE Life Sciences (WVE) Singapore $1.169B 0.00
Principia Biopharma (PRNB) United States $1.156B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.141B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Fate Therapeutics (FATE) United States $1.067B 0.00
Zealand Pharma (ZEAL) Denmark $0.974B 0.00
Revance Therapeutics (RVNC) United States $0.909B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.908B 7.64
ZIOPHARM Oncology Inc (ZIOP) United States $0.889B 0.00
Codexis (CDXS) United States $0.888B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.870B 0.00
Precision BioSciences (DTIL) United States $0.856B 0.00
Pharming Group (PHGUF) Netherlands $0.840B 0.00
Vericel (VCEL) United States $0.836B 311.83
Intellia Therapeutics (NTLA) United States $0.834B 0.00
Anika Therapeutics (ANIK) United States $0.812B 26.34
MiMedx (MDXG) United States $0.797B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.792B 0.00
Twist Bioscience (TWST) United States $0.748B 0.00
Heska (HSKA) United States $0.746B 190.58
ANI Pharmaceuticals (ANIP) United States $0.720B 12.27
Adverum Biotechnologies (ADVM) United States $0.691B 0.00
DBV Technologies S.A (DBVT) France $0.688B 0.00
Cara Therapeutics (CARA) United States $0.678B 0.00
UROGEN PHARMA (URGN) United States $0.660B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.650B 0.00
Clovis Oncology (CLVS) United States $0.640B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.629B 0.00
Mesoblast (MESO) Australia $0.616B 0.00
Cellectis S.A (CLLS) France $0.614B 0.00
Sorrento Therapeutics (SRNE) United States $0.614B 0.00
GENFIT S.A (GNFT) France $0.606B 0.00
BioDelivery Sciences (BDSI) United States $0.605B 0.00
Cytokineticsorporated (CYTK) United States $0.578B 0.00
Retrophin (RTRX) United States $0.564B 0.00
Agenus (AGEN) United States $0.552B 0.00
PHARMA MAR SA (PHMMF) Spain $0.549B 0.00
Kadmon Holdings (KDMN) United States $0.542B 0.00
Intra-Cellular Therapies (ITCI) United States $0.537B 0.00
AC Immune SA (ACIU) Switzerland $0.535B 12.38
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Stemline Therapeutics (STML) United States $0.502B 0.00
Prothena (PRTA) Ireland $0.496B 0.00
Dynavax Technologies (DVAX) United States $0.466B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.387B 0.00
Bellus Health (BLU) Canada $0.384B 0.00
Arcus Biosciences (RCUS) United States $0.377B 0.00
Puma Biotechnology (PBYI) United States $0.364B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.362B 0.00
PDL BioPharma (PDLI) United States $0.354B 8.86
OSMOTICA PHARM (OSMT) United States $0.351B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.351B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.351B 2.43
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
Cellular Biomedicine (CBMG) United States $0.338B 0.00
Pfenex (PFNX) United States $0.334B 0.00
Avid Bioservices (CDMO) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.312B 0.00
Geron (GERN) United States $0.300B 0.00
Kindred Biosciences (KIN) United States $0.299B 0.00
CytomX Therapeutics (CTMX) United States $0.288B 0.00
Kamada (KMDA) Israel $0.287B 8.38
Cue Biopharma (CUE) United States $0.276B 0.00
Compugen (CGEN) Israel $0.274B 0.00
Cel-Sci (CVM) United States $0.267B 0.00
Albireo Pharma (ALBO) United States $0.266B 0.00
Seres Therapeutics (MCRB) United States $0.263B 0.00
ADMA Biologics Inc (ADMA) United States $0.259B 0.00
Sutro Biopharma (STRO) United States $0.258B 0.00
Inovio Pharmaceuticals (INO) United States $0.255B 0.00
MannKind (MNKD) United States $0.254B 0.00
Scholar Rock Holding (SRRK) United States $0.246B 0.00
Exicure (XCUR) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Biofrontera AG (BFRA) Germany $0.232B 0.00
Theratechnologies (THTX) Canada $0.231B 0.00
Spero Therapeutics (SPRO) United States $0.215B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.214B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
ChromaDex (CDXC) United States $0.212B 0.00
XOMA (XOMA) United States $0.208B 0.00
Athersys (ATHX) United States $0.205B 0.00
Syros Pharmaceuticals (SYRS) United States $0.203B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.200B 0.00
Mersana Therapeutics (MRSN) United States $0.194B 0.00
Senesco Technologies (ELOX) United States $0.193B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.193B 0.00
Affimed (AFMD) Germany $0.186B 0.00
Palatin Technologies (PTN) United States $0.183B 4.99
IVERIC Bio (ISEE) United States $0.172B 0.00
ARAVIVE, INC (ARAV) United States $0.169B 0.00
Dyadic (DYAI) United States $0.168B 0.00
Abeona Therapeutics (ABEO) United States $0.166B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.159B 0.00
Cerecor (CERC) United States $0.157B 0.00
CorMedix Inc (CRMD) United States $0.155B 0.00
VBI Vaccines (VBIV) United States $0.154B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.152B 0.00
Five Prime Therapeutics (FPRX) United States $0.146B 0.00
Alcobra (ARCT) United States $0.145B 0.00
TELA Bio (TELA) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.140B 0.00
NantKwest (NK) United States $0.139B 0.00
Prometic Life Sciences (LMNL) Canada $0.137B 0.00
Proteostasis Therapeutics (PTI) United States $0.135B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.132B 0.00
Aptinyx (APTX) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Protagonist Therapeutics (PTGX) United States $0.128B 0.00
Novavax (NVAX) United States $0.127B 0.00
SESEN BIO, INC (SESN) United States $0.126B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Arsanis (XFOR) United States $0.126B 0.00
Celyad SA (CYAD) Belgium $0.122B 0.00
BioTime (LCTX) United States $0.120B 6.15
AVEO Pharmaceuticals (AVEO) United States $0.119B 0.00
Arbutus Biopharma (ABUS) Canada $0.114B 0.00
Verastem (VSTM) United States $0.106B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
Emmaus Life Sciences (EMMA) United States $0.104B 0.00
OvaScience (MLND) United States $0.103B 0.00
PHASEBIO PHARMA (PHAS) United States $0.100B 0.00
Strongbridge Biopharma (SBBP) United States $0.099B 2.65
Acorda Therapeutics (ACOR) United States $0.099B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.099B 0.00
Aduro Biotech (ADRO) United States $0.095B 0.00
Adocia (ADOCY) France $0.086B 0.00
Antibe Therapeutics (ATBPF) Canada $0.084B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Liquidia Technologies (LQDA) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Catalyst Biosciences (CBIO) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Trevena (TRVN) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Curis (CRIS) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Protalix BioTherapeutics (PLX) Israel $0.047B 0.00
Orgenesis (ORGS) United States $0.047B 3.03
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Checkpoint Therapeutics (CKPT) United States $0.046B 0.00
Oncobiologics (OTLK) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.041B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Evogene (EVGN) Israel $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
BioCardia (BCDA) United States $0.033B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Aptevo Therapeutics (APVO) United States $0.029B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Entera Bio (ENTX) Israel $0.025B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Soligenix (SNGX) United States $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.020B 0.00
VistaGen Therapeutics (VTGN) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Advaxis (ADXS) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
IBio (IBIO) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.003B 0.00